 | |
- close
- close
|
PR Newswire
Nov 2
Comment
In the news release, Helmets for Hope Campaign and Gala, issued 02-Nov-2009 by American Epilepsy Outreach Foundation over PR Newswire, we are advised by the organization that the first paragraph, second sentence, should read " The Lennox Gastaut
FierceBiotech
Nov 2
Comment
Quintiles Transnational has struck a deal to conduct 11 mid-stage cancer trials on six new therapies in development at Eisai in exchange for an unspecified array of milestone payments. Quintiles has been steadily building up its expertise in the...
PR Newswire
Oct 30
Comment
WOODCLIFF LAKE, N.J., Oct. 30 /PRNewswire/ -- Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or
PR Newswire
Oct 29
Comment
WOODCLIFF LAKE, N.J., Oct. 29 /PRNewswire/ -- Eisai Inc. and the Alzheimer's Association announce today that Heather Greene, PharmD is the recipient of the 2009 C.A.R.E. Pharmacy Award. (Photo: http://www.newscom.com/cgi-bin/prnh/20091029/NY00986 )
PR Newswire
Oct 28
Comment
EXTON, Pa., Oct. 28 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a license agreement with Centocor Ortho Biotech Inc. for development and commercialization of an antibody that targets a
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ESALY AT A GLANCE
References
| ||||||
|
|
